Division of Medical Ethics Research
Research in NYU Langone’s Division of Medical Ethics centers on timely and challenging ethical issues in medicine, population health, and biotechnology. We use our research to advise healthcare centers, patients, patient advocates, the pharmaceutical industry, policymakers, state and federal legislators, and other groups in the medical and health industries on ways to integrate ethics into their policies and practices.
We direct the following research initiatives.
Preapproval Access to Investigational Medical Products
We work to ensure fairness and transparency in how patients access investigational drugs, biologics, and devices in development in the United States. To that end, we created the Working Group on Compassionate Use and Preapproval Access (CUPA) in 2014, which studies, raises awareness, and makes recommendations about the ethical issues surrounding compassionate use and other efforts to facilitate access to investigational medical products. We also collaborated on the Compassionate Use Advisory Committees, the first independent bodies of their kind created to advise a pharmaceutical company on the ethical, transparent allocation of its products in development.
Gender Affirmation Project
Our Gender Affirmation Project (GAP) proactively identifies ethical issues related to gender-affirming care for transgender and gender diverse individuals, including hormonal and surgical interventions.
NYU-University of Ghana Research Integrity Training Program
The NYU-University of Ghana Research Integrity Training Program is a collaborative endeavor between these two universities designed to develop expertise related to research ethics, research integrity, and research governance in Ghana.
Through the Transplant Ethics Project, we engage in a broad range of ethical and policy issues related to organ transplantation, including organ procurement, fair allocation of organs, ensuring equity in the transplant candidate selection process, living and deceased donor considerations, and transplant financing. We are also working to produce a report on the ethics of using newly deceased persons to test bioengineered lobes of lung for eventual clinical use. Learn more about our research on transplant ethics.
Vaccine Ethics Project
Researchers in the Vaccine Ethics Project study the growth of and develop policies to counter vaccine hesitancy and disseminate information and strategies needed to confront anti-vaccine advocates.
Working Group on Pediatric Gene Therapy and Medical Ethics
The Working Group on Pediatric Gene Therapy and Medical Ethics addresses ethical issues surrounding genetic interventions in infants and children, including research design, patient autonomy, sibling and family involvement, fairness in access, and accuracy of information. It is funded by a gift from Parent Project Muscular Dystrophy.
Our faculty are involved in external research projects, such as GE2P2 Global: Governance, Ethics, Evidence, Policy, Practice, which develops ethical guidance and policy concerning fair, equitable, and effective access to pharmaceutical products. This includes drugs, biologics, vaccines, essential medicines, and medical devices. GE2P2 Global focuses on general bioethical issues associated with research, discovery, and clinical trials for investigational medicines; compassionate use, prelicensure, and expanded access programs; and access to vaccines and essential medicines in low-resource settings and humanitarian contexts globally. GE2P2 Global also advises commercial, not-for-profit, nongovernmental, and public-sector biopharmaceutical organizations on bioethics and policy issues and challenges.